RMI2 is a novel prognostic and predictive biomarker for breast cancer.
Zhang L, Hao C, Han B, Zeng G, Han L, Cao C, Liu H, Zhong Z, Zhao X, Wang J, Zhang Q.
Zhang L, et al. Among authors: liu h.
Cancer Med. 2023 Apr;12(7):8331-8350. doi: 10.1002/cam4.5533. Epub 2022 Dec 19.
Cancer Med. 2023.
PMID: 36533385
Free PMC article.